☰

Deng Pan, Ph.D. - Publications

Affiliations: 
2010 Molecular & Cell Biology University of California, Berkeley, Berkeley, CA, United States 
Area:
Signal transduction pathways mediated by receptors and the mechanisms controlling the activity of the receptor kinases
Tree Info Grants Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Jiang L, He B, Pan D, Luo K, Yi Q, Gu Z. Anti-Cancer Efficacy of Paclitaxel Loaded in pH Triggered Liposomes. Journal of Biomedical Nanotechnology. 12: 79-90. PMID 27301174  0.496
2016 Jiang L, Li L, He B, Pan D, Luo K, Yi Q, Gu Z. Anti-cancer efficacy of Paclitaxel loaded in pH triggered liposomes Journal of Biomedical Nanotechnology. 12: 79-90. DOI: 10.1166/jbn.2016.2123  0.454
2016 Guo C, Hu J, Bains A, Pan D, Luo K, Li N, Gu Z. The potential of peptide dendron functionalized and gadolinium loaded mesoporous silica nanoparticles as magnetic resonance imaging contrast agents Journal of Materials Chemistry B. 4: 2322-2331. DOI: 10.1039/c5tb02709h  0.437
2015 She W, Pan D, Luo K, He B, Cheng G, Zhang C, Gu Z. PEGylated Dendrimer-Doxorubicin Cojugates as pH-Sensitive Drug Delivery Systems: Synthesis and In Vitro Characterization. Journal of Biomedical Nanotechnology. 11: 964-78. PMID 26353586 DOI: 10.1166/jbn.2015.1865  0.48
2014 Pan D, She W, Guo C, Luo K, Yi Q, Gu Z. PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy. Biomaterials. 35: 10080-92. PMID 25263685 DOI: 10.1016/j.biomaterials.2014.09.006  0.498
2014 Li N, Li N, Yi Q, Luo K, Guo C, Pan D, Gu Z. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent. Biomaterials. 35: 9529-45. PMID 25145854 DOI: 10.1016/j.biomaterials.2014.07.059  0.499
2014 Zhang C, Pan D, Luo K, She W, Guo C, Yang Y, Gu Z. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy. Advanced Healthcare Materials. 3: 1299-308. PMID 24706635 DOI: 10.1002/adhm.201300601  0.494
2013 Yang Y, Pan D, Luo K, Li L, Gu Z. Biodegradable and amphiphilic block copolymer-doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy. Biomaterials. 34: 8430-43. PMID 23896006 DOI: 10.1016/j.biomaterials.2013.07.037  0.492
2012 Pan D, Zhu Q, Conboy MJ, Conboy IM, Luo K. SnoN activates p53 directly to regulate aging and tumorigenesis. Aging Cell. 11: 902-11. PMID 22805162 DOI: 10.1111/J.1474-9726.2012.00857.X  0.447
2009 Pan D, Zhu Q, Luo K. SnoN functions as a tumour suppressor by inducing premature senescence. The Embo Journal. 28: 3500-13. PMID 19745809 DOI: 10.1038/emboj.2009.250  0.505
2005 Pan D, Estévez-Salmerón LD, Stroschein SL, Zhu X, He J, Zhou S, Luo K. The integral inner nuclear membrane protein MAN1 physically interacts with the R-Smad proteins to repress signaling by the transforming growth factor-{beta} superfamily of cytokines. The Journal of Biological Chemistry. 280: 15992-6001. PMID 15647271 DOI: 10.1074/Jbc.M411234200  0.551
Show low-probability matches.